F10 and pancreatic neoplasm: In addition, the abundance of FX+ TAM in the TME of mice with different tumor models (Figure 5H) as well as in the TME of patients with pancreatic cancer (Figure 5I) increased with tumor size, indicating that expansion of FX+ TAM is a potential marker for tumor progression.